STOCK TITAN
  1. Home
  2. Sec-filings
  3. KRMD
  4. [Form 4] KORU Medical Systems, Inc. Insider Trading Activity

Horton Capital (NASDAQ: KRMD) reports 3,571-share stock grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

KORU Medical Systems director and major holder reports stock grant. A Form 4 shows an entity associated with Horton Capital receiving a grant or other acquisition of 3,571 shares of KORU Medical common stock at $0.00 per share.

After this grant, Horton Capital Partners Fund, L.P. is reported with 5,069,541 shares held indirectly, while Joseph M. Manko Jr. also reports 782,547 shares held directly. The filing reflects a compensation or award-type acquisition rather than an open-market purchase or sale.

Positive

  • None.

Negative

  • None.
Insider Manko Joseph M. Jr., Horton Capital Management, LLC, Horton Capital Partners, LLC, Horton Capital Partners Fund, L.P.
Role null | null | null | null
Type Security Shares Price Value
Grant/Award Common Stock 3,571 $0.00 --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 5,069,541 shares (Indirect, By Horton Capital Partners Fund, LP); Common Stock — 782,547 shares (Direct, null)
Footnotes (1)
  1. See Exhibit 99.1 to this Form 4 for explanation of note (1). See Exhibit 99.1 to this Form 4 for explanation of note (2).
Grant shares 3,571 shares Common Stock grant/award acquisition on 2026-06-30
Grant price $0.00 per share Price per share for 3,571-share grant
Indirect holdings 5,069,541 shares Common Stock held indirectly by Horton Capital Partners Fund, L.P. after grant
Direct holdings 782,547 shares Common Stock held directly by Joseph M. Manko Jr. as of 2026-06-30
Acquisition transactions 1 transaction Grant/award acquisition events in transaction summary
grant/award acquisition financial
"transaction_action: "grant/award acquisition" for 3,571 Common Stock shares"
indirect ownership financial
"direct_or_indirect: "I" with nature_of_ownership "By Horton Capital Partners Fund, LP""
ten percent owner financial
"is_ten_percent_owner: 1 for Horton Capital-related reporting persons"
Form 4 regulatory
"See Exhibit 99.1 to this Form 4 for explanation of note (1)."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Manko Joseph M. Jr.
(Last)(First)(Middle)
1717 ARCH STREET
37TH FLOOR
(Street)
PHILADELPHIA PENNSYLVANIA 19103
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
KORU Medical Systems, Inc. [ KRMD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
XForm filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/30/2026A3,571A$0(1)5,069,541IBy Horton Capital Partners Fund, LP(2)
Common Stock782,547D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
1. Name and Address of Reporting Person*
Manko Joseph M. Jr.
(Last)(First)(Middle)
1717 ARCH STREET
37TH FLOOR
(Street)
PHILADELPHIA PENNSYLVANIA 19103
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
XDirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Horton Capital Management, LLC
(Last)(First)(Middle)
1717 ARCH STREET
37TH FLOOR
(Street)
PHILADELPHIA PENNSYLVANIA 19103
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Horton Capital Partners, LLC
(Last)(First)(Middle)
1717 ARCH STREET
37TH FLOOR
(Street)
PHILADELPHIA PENNSYLVANIA 19103
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
1. Name and Address of Reporting Person*
Horton Capital Partners Fund, L.P.
(Last)(First)(Middle)
1717 ARCH STREET
37TH FLOOR
(Street)
PHILADELPHIA PENNSYLVANIA 19103
(City)(State)(Zip)
UNITED STATES
(Country)
Relationship of Reporting Person(s) to Issuer
DirectorX10% Owner
Officer (give title below)Other (specify below)
Explanation of Responses:
1. See Exhibit 99.1 to this Form 4 for explanation of note (1).
2. See Exhibit 99.1 to this Form 4 for explanation of note (2).
Remarks:
The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.
/s/ Joseph M. Manko, Jr.07/01/2026
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Management, LLC07/01/2026
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC07/01/2026
/s/ Joseph M. Manko, Jr., Managing Member of Horton Capital Partners, LLC, the General Partner of Horton Capital Partners Fund, LP07/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider activity did KRMD report in this Form 4 filing?

The filing reports a grant or other acquisition of 3,571 shares of KORU Medical common stock. These shares were acquired at $0.00 per share and increase the indirect holdings reported for Horton Capital Partners Fund, L.P. to 5,069,541 shares.

Who is the main reporting person in the KRMD Form 4 and what is their role?

The filing lists Joseph M. Manko Jr. as a director and ten percent owner of KORU Medical Systems. It also includes Horton Capital-related entities as ten percent owners, with Horton Capital Partners Fund, L.P. holding the newly granted 3,571 shares indirectly.

Was the KRMD insider transaction an open-market buy or sell of shares?

No, the reported activity is categorized as a grant, award, or other acquisition of 3,571 shares at $0.00 per share. This indicates a compensation or award-type event, not an open-market purchase or sale of KORU Medical Systems stock.

How many KRMD shares does Horton Capital Partners Fund, L.P. hold after this grant?

After receiving the 3,571-share grant, Horton Capital Partners Fund, L.P. is reported as indirectly holding 5,069,541 shares of KORU Medical common stock. This reflects the updated position shown in the Form 4 filing following the award transaction.

What direct KRMD shareholding does Joseph M. Manko Jr. report in this Form 4?

Joseph M. Manko Jr. reports direct ownership of 782,547 shares of KORU Medical common stock. This figure appears as a holding entry in the Form 4 and represents his directly owned position separate from the indirect Horton Capital-related holdings.

How many acquisition-type transactions are reported in this KRMD Form 4?

The Form 4 shows one acquisition-type transaction: a grant or award of 3,571 shares to Horton Capital Partners Fund, L.P. It also includes a holding line for 782,547 directly owned shares, which records position but does not represent a new transaction.